| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 4.556 | 170.405 | 288.811 | 329.045 | 302.279 | 390.907 | 358.352 | 381.358 | 401.707 |
| Total Income - EUR | - | 4.556 | 170.405 | 288.811 | 335.864 | 320.915 | 398.666 | 364.706 | 384.010 | 406.321 |
| Total Expenses - EUR | - | 4.351 | 38.257 | 75.894 | 119.548 | 141.364 | 116.497 | 144.669 | 137.970 | 158.772 |
| Gross Profit/Loss - EUR | - | 205 | 132.148 | 212.916 | 216.316 | 179.551 | 282.169 | 220.038 | 246.040 | 247.549 |
| Net Profit/Loss - EUR | - | 114 | 130.444 | 210.028 | 212.977 | 176.950 | 278.260 | 216.524 | 242.294 | 209.521 |
| Employees | - | 1 | 2 | 5 | 5 | 5 | 5 | 6 | 5 | 4 |
Check the financial reports for the company - Cardiozone Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 197 | 0 | 12.270 | 66.255 | 62.740 | 44.277 | 80.333 | 82.935 | 79.981 |
| Current Assets | - | 6.451 | 133.468 | 201.391 | 356.645 | 334.597 | 620.100 | 316.069 | 418.483 | 446.680 |
| Inventories | - | 2.010 | 1.307 | 1.956 | 548 | 413 | 15.600 | 8.067 | 16.109 | 13.948 |
| Receivables | - | 0 | 11 | 11 | 11 | 187 | 524 | 152.301 | 186.522 | 0 |
| Cash | - | 4.440 | 132.150 | 199.425 | 356.086 | 333.997 | 603.976 | 155.702 | 215.852 | 432.732 |
| Shareholders Funds | - | 448 | 131.213 | 210.802 | 419.697 | 390.459 | 659.866 | 217.254 | 243.021 | 210.245 |
| Social Capital | - | 334 | 657 | 645 | 632 | 620 | 606 | 608 | 606 | 603 |
| Debts | - | 6.245 | 2.255 | 2.860 | 3.203 | 6.879 | 4.512 | 179.149 | 258.396 | 317.179 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Cardiozone Med Srl